Episode 299: Androgen receptor ligand-directed degrader BMS-986365

Listen now

Description

Dana Rathkopf describes phase 1 data for the androgen receptor ligand-directed degrader in prostate cancer

More Episodes

Aditya Bagrodia describes three new drugs/studies in NMIBC.

Published 06/21/24

Silke Gillessen joins Tom and Brian, who give their opinion on the data and new 'Take Home Message' format.

Published 06/10/24

Published 06/10/24